#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fontan procedure Neuroendocrine carcinoma metastatic Wiskott-Aldrich syndrome Thalassaemia Spinal cord injury Rett syndrome Neuroendocrine carcinoma Small intestine neuroendocrine tumour X-linked lymphoproliferative syndrome Acute promyelocytic leukaemia Bulbospinal muscular atrophy congenital Herpes simplex Fibrous dysplasia of bone Follicular lymphoma stage III Immune-mediated renal disorder More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Life with Disease Retinoblastoma Acquired haemophilia – Diagnostics Netherton’s syndrome – Life with Disease Haemophilia B without inhibitors – Trials in Disease Angiosarcoma non-metastatic – Life with Disease Breast angiosarcoma metastatic – Treatment Nephroblastoma – Life with Disease Hairy cell leukaemia – Trials in Disease Glomerulonephritis rapidly progressive More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lebrikizumab Magnesium Haloperidol Decanoate Asp1570 Pilocarpine Nitrate Gentamicin Sulfate ATTR-01 PHENTOLAMINE MESILATE Imsidolimab ZINC CHLORIDE Valproic Acid Peposertib Dexamethasone Phosphate Zagociguat Lenograstim Lu Ag09222 Alpha1H FRUQUINTINIB ULTEVURSEN Ipratropium Bromide More therapies…

    Learn about Your Condition

    Habitual abortion Stress Mental disorder Carotid artery occlusion Mantle cell lymphoma recurrent Peritoneal dialysis Spinal muscular atrophy Tumour thrombosis Bronchitis External cephalic version Muscular dystrophy Macular degeneration Haematological malignancy Tendon injury Choroidal dystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Teclistamab
    Belgium France Germany Italy The Netherlands Spain +1

  • Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Isatuximab
    • Bortezomib
    • Dexamethasone
    Germany

  • Study of Mitapivat for Adults with Sickle Cell Disease

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Mitapivat
    The Netherlands

  • Study on the Effectiveness of Ivosidenib in Patients with IDH1 Mutated Myelodysplastic Syndrome

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Ivosidenib
    • Azacitidine
    France

  • Study on Early Treatment with Teclistamab and Talquetamab for Patients with Newly Diagnosed High-Risk Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Talquetamab
    • Bortezomib
    • Daratumumab
    Spain

  • Study of venetoclax with fludarabine, cytarabine and idarubicin combination therapy in newly diagnosed patients with intermediate or high-risk Acute Myeloid Leukemia

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Fludarabine Phosphate
    • Idarubicin
    • Venetoclax
    Italy
Previous Page
1 … 51 52 53 54 55 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!